Periconceptional intake of folic acid among low-risk women in Canada: Summary of a workshop aiming to align prenatal folic acid supplement composition with current expert guidelines

46Citations
Citations of this article
142Readers
Mendeley users who have this article in their library.

Abstract

The Government of Canada and the Society of Obstetricians and Gynaecologists of Canada both recommend a daily multivitamin supplement containing 400 μg folic acid (FA) for the primary prevention of neural tube defects among low-risk women from before conception and throughout lactation. Prenatal supplements marketed and prescribed in Canada typically exceed the recommended dose, usually providing ≥1000 μg FA/d. This high daily dose, coupled with staple-food FA fortification, has resulted in the observation of very high blood folate concentrations among reproductive-aged women consuming FA-containing supplements. The long-term consequences of high folate status on fetal development are unknown; however, evidence from animal studies and some human epidemiologic data suggest potential adverse consequences. To address this issue, a workshop was convened with the overall goal to identify challenges and solutions to aligning supplemental FA intakes with current evidence-based recommendations. Thirty-eight stakeholders from academia, industry, government, and health professional groups participated. Group discussions facilitated the identification and prioritization of 5 key challenges for which solutions and implementation strategies were proposed. The 5 themes encompassed clarity and harmonization of evidence-based guidelines, reformulation or relabeling of FA-containing supplements, access to FA for all women, knowledge dissemination strategies and education of the public and health care professionals, and attitude change to overcome the perception of “more is better.” A combination of the proposed implementation strategies involving all key stakeholders and directed to health care professionals and the public may enable a sustainable change to align FA intake during the periconceptional period with evidence-based recommendations.

References Powered by Scopus

Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study

0
3797Citations
N/AReaders
Get full text

Prevention of the First Occurrence of Neural-Tube Defects by Periconceptional Vitamin Supplementation

2828Citations
N/AReaders
Get full text

Prevention of neural-tube defects with folic acid in China

1309Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Dietary Supplement Use and Its Micronutrient Contribution During Pregnancy and Lactation in the United States

63Citations
N/AReaders
Get full text

Clinical Implications of Folate Transport in the Central Nervous System

34Citations
N/AReaders
Get full text

Guideline No. 410: Prevention, Screening, Diagnosis, and Pregnancy Management for Fetal Neural Tube Defects

31Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Lamers, Y., MacFarlane, A. J., O’Connor, D. L., & Fontaine-Bisson, B. (2018). Periconceptional intake of folic acid among low-risk women in Canada: Summary of a workshop aiming to align prenatal folic acid supplement composition with current expert guidelines. American Journal of Clinical Nutrition, 108(6), 1357–1368. https://doi.org/10.1093/ajcn/nqy212

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 39

67%

Researcher 9

16%

Professor / Associate Prof. 6

10%

Lecturer / Post doc 4

7%

Readers' Discipline

Tooltip

Medicine and Dentistry 24

41%

Nursing and Health Professions 20

34%

Social Sciences 7

12%

Agricultural and Biological Sciences 7

12%

Save time finding and organizing research with Mendeley

Sign up for free